Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with <sup>64</sup>Cu Using NOTA and NODAGA

<div>Uptake of <sup>64</sup>Cu-NODAGA-ZHER2:S1 (a) or <sup>64</sup>Cu-NOTA-ZHER2:S1 (b) at 2 h after injection in mice bearing either HER2-positive xenografts (SKOV-3) or HER2-negative xenografts (Ramos). The data are presented as mean ± SD for four mice.</div>

Contrast Media & Molecular Imaging

fig4

Figure 4

Figure 4: Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with <sup>64</sup>Cu Using NOTA and NODAGA 

Contrast Media & Molecular Imaging

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA

Figure 4

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with ⁶⁴Cu Using NOTA and NODAGA